Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Schulz

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
Ophthalmology|February 4, 2019
Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum DisorderYuyi You, Ling Zhu, Ting Zhang, et al.
American Journal of Nephrology|February 24, 2020
Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney DiseaseMarta Gil-Ortega, Elena Vega-Martín, Miriam Martín-Ramos, et al.
Orphanet Journal of Rare Diseases|January 8, 2026
A timeline of symptom onset and disease progression in CLN3 diseaseIneka T Whiteman, Anthony L Cook, Erika F Augustine, et al.
Journal of Medical Genetics|June 14, 2012
Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy geneMaria Kousi, Verneri Anttila, Angela Schulz, et al.
Thyroid : Official Journal of the American Thyroid Association|March 8, 2020
Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 ExpressionNina-Maria Wilpert, Martin Krueger, Robert Opitz, et al.
The Journal of Biological Chemistry|November 24, 2005
The CLN9 protein, a regulator of dihydroceramide synthaseAngela Schulz, Talal Mousallem, Maya Venkataramani, et al.
International Journal of Molecular Sciences|January 8, 2023
Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney DiseaseFrancisco Javier Manzano-Lista, Marta Sanz-Gómez, Daniel González-Moreno, et al.
Orphanet Journal of Rare Diseases|May 13, 2021
Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2)Paul Gissen, Nicola Specchio, Andrew Olaye, et al.
Hypertension (Dallas, Tex. : 1979)|January 30, 2023
Studies in Zebrafish and Rat Models Support Dual Blockade of EP2 and EP4 (Prostaglandin E<sub>2</sub> Receptors Type 2 and 4) for Renoprotection in Glomerular Hyperfiltration and AlbuminuriaAikaterini Kourpa, Angela Schulz, Eva Mangelsen, et al.
Aging Brain|March 13, 2023
Evaluating associations of RNFL thickness and multifocal VEP with cognitive assessment and brain MRI volumes in older adults: Optic nerve decline and cognitive change (ONDCC) initiativeTing Shen, Samran Sheriff, Yuyi You, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
Ophthalmology|February 4, 2019
Evidence of Müller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum DisorderYuyi You, Ling Zhu, Ting Zhang, et al.
American Journal of Nephrology|February 24, 2020
Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney DiseaseMarta Gil-Ortega, Elena Vega-Martín, Miriam Martín-Ramos, et al.
Orphanet Journal of Rare Diseases|January 8, 2026
A timeline of symptom onset and disease progression in CLN3 diseaseIneka T Whiteman, Anthony L Cook, Erika F Augustine, et al.
Journal of Medical Genetics|June 14, 2012
Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy geneMaria Kousi, Verneri Anttila, Angela Schulz, et al.
Thyroid : Official Journal of the American Thyroid Association|March 8, 2020
Spatiotemporal Changes of Cerebral Monocarboxylate Transporter 8 ExpressionNina-Maria Wilpert, Martin Krueger, Robert Opitz, et al.
The Journal of Biological Chemistry|November 24, 2005
The CLN9 protein, a regulator of dihydroceramide synthaseAngela Schulz, Talal Mousallem, Maya Venkataramani, et al.
International Journal of Molecular Sciences|January 8, 2023
Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney DiseaseFrancisco Javier Manzano-Lista, Marta Sanz-Gómez, Daniel González-Moreno, et al.
Orphanet Journal of Rare Diseases|May 13, 2021
Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2)Paul Gissen, Nicola Specchio, Andrew Olaye, et al.
Hypertension (Dallas, Tex. : 1979)|January 30, 2023
Studies in Zebrafish and Rat Models Support Dual Blockade of EP2 and EP4 (Prostaglandin E<sub>2</sub> Receptors Type 2 and 4) for Renoprotection in Glomerular Hyperfiltration and AlbuminuriaAikaterini Kourpa, Angela Schulz, Eva Mangelsen, et al.
Aging Brain|March 13, 2023
Evaluating associations of RNFL thickness and multifocal VEP with cognitive assessment and brain MRI volumes in older adults: Optic nerve decline and cognitive change (ONDCC) initiativeTing Shen, Samran Sheriff, Yuyi You, et al.
Pageof 19